Winn Career Development Award Expands to Neuropsychiatry to Diversify Clinical Trial Research and Community Engagement

The Winn Career Development Award expands to neuropsychiatry, offering $240,000 to physicians researching inclusive trials for Alzheimer’s and Schizophrenia.

By: AXL Media

Published: Mar 19, 2026, 3:22 PM EDT

Source: Information for this report was sourced from The Robert A. Winn Excellence in Clinical Trials Award Program

Inclusion of Neuropsychiatry in National Research Training

In a significant expansion of its mission to diversify the clinical research landscape, the Robert A. Winn Excellence in Clinical Trials Award Program has announced that neuropsychiatry specialists are now eligible for its career development track. According to program officials, this move marks the first time that investigator-physicians in this field can apply for the two-year curriculum. The initiative is designed to address the persistent lack of representation in clinical trials for complex neurological and psychiatric disorders. By integrating neuropsychiatry, the program seeks to build a national network of scientists capable of reaching underrepresented populations who have historically been excluded from cutting-edge medical advancements.

Financial Support and Curriculum for Early Stage Scientists

The Career Development Award provides a substantial financial commitment to support the professional growth of early-stage physician-scientists. According to the award guidelines, scholars receive a $240,000 grant over two years, which is specifically intended to protect 40% of their professional time for research and training. This protected time allows participants to focus on a rigorous curriculum centered on community engagement and the technical demands of conducting scientifically sound clinical trials. The program, which began in 2020, has already supported hundreds of researchers in fields such as oncology and cardiovascular disease, providing the resources necessary to bridge the gap between laboratory discovery and community health.

Targeting Critical Neurological and Mental Health Conditions

The leadership of the Winn Awards has identified several high-priority areas of study for the upcoming sixth cohort of researchers. According to Program Director Ali Gemma, the committee is particularly interested in applicants whose work focuses on debilitating conditions such as Alzheimer’s Disease, Parkinson’s Disease, ALS, Multiple Sclerosis, and Schizophrenia. The expansion into these areas recognizes that while significant progress has been made in understanding these disorders, the clinical trials used to test new treatments often fail to reflect the diverse patient populations impacted by them. The goal of the program is to produce clinical trialists who prioritize inclusivity and commun...